Executive Chairman Sean Downes Sells $885K of UVE Stock Near 52-Week High
UVE sits 93% above its 52-week low of $22.87.
Summary
Universal Insurance Holdings' Executive Chairman Sean Downes sold $885,364 worth of shares near the 52-week high, extending a three-month selling streak that now exceeds $2.4 million.
Key Events · Ownership and Investor Activity · UVE
-
Executive Chairman Sells $885K
Sean Downes sold 20,000 shares at an average price of $44.27, generating $885,364 in proceeds. The sale occurred on August 5, 2026, near the stock's 52-week high of $45.15.
-
Ongoing Insider Selling Pattern
This is the third Form 4 filing by Downes in 90 days, bringing his total open-market sales to over $2.4 million. The pattern coincides with strong Q2 results and a rising stock price.
-
Post-Transaction Holdings Remain Substantial
Downes still directly holds 1,104,645 shares, plus indirect holdings through spouse and children, indicating continued significant exposure despite the sales.
-
Context: Strong Q2 and Refinancing
The sale follows a Q2 earnings beat (adjusted EPS $1.84 vs. $1.62 consensus) and a $100 million debt refinancing, suggesting the insider may be taking profits after positive operational developments.
Analysis · UVE · Finance
Executive Chairman Sean Downes sold 20,000 shares for $885,364 at an average price of $44.27, continuing a pattern of insider selling that has now totaled over $2.4 million in the past three months. The sale occurred near the stock's 52-week high of $45.15, following strong Q2 earnings that beat estimates. While the transaction represents only 0.072% of the company's market cap, the repeated selling by a key insider at elevated prices raises questions about management's view of current valuation, especially given the recent $100 million debt refinancing and the completion of a major reinsurance program.
At the time of this filing, UVE was trading at $44.15 on NYSE in the Finance sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $22.87 to $45.15. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.